Germline mutations in the tumor suppressor genes BRCA1 and BRCA2 predispose to familial breast and/or ovarian cancer. The lifetime risk of members of families with genetic predisposition depends on the mutations of susceptibility genes. BRCA1 mutations seem to confer the highest risk of developing neoplastic diseases. Apart from breast and ovarian cancer mutations in BRCA, related pathways are supposed to confer a smaller risk for additional cancers (colon, melanoma, pancreas, lymphoma, prostate, liver). All these tumors have an inherited component not necessarily associated with genetic susceptibility to BRCA genes. To date he main focus of this review has been argued still with difficulty. Just a deeper and complete evaluation of the topic will allow to establish how much is the contribution of BRCA mutations in different types of cancers other than breast and ovary.

Di Gaudio, F., Calo, V., La Paglia, L., Bruno, L., Di Piazza, F., Margarese, N., et al. (2012). What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary?. CURRENT WOMEN'S HEALTH REVIEWS, 8, 65-71 [http://dx.doi.org/10.2174/157340412799079327].

What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary?

DI GAUDIO, Francesca;CALO', Valentina;LA PAGLIA, Laura;BRUNO, Leonardo;DI PIAZZA, Fabiola;MARGARESE, Naomi;P. Guadagna, F;GUARNERI, Giovanni;CICERO, Giuseppe;CUCINELLA, Gaspare;PANTUSO, Gianni;BAZAN, Viviana;RUSSO, Andrea;RUSSO, Antonio
2012

Abstract

Germline mutations in the tumor suppressor genes BRCA1 and BRCA2 predispose to familial breast and/or ovarian cancer. The lifetime risk of members of families with genetic predisposition depends on the mutations of susceptibility genes. BRCA1 mutations seem to confer the highest risk of developing neoplastic diseases. Apart from breast and ovarian cancer mutations in BRCA, related pathways are supposed to confer a smaller risk for additional cancers (colon, melanoma, pancreas, lymphoma, prostate, liver). All these tumors have an inherited component not necessarily associated with genetic susceptibility to BRCA genes. To date he main focus of this review has been argued still with difficulty. Just a deeper and complete evaluation of the topic will allow to establish how much is the contribution of BRCA mutations in different types of cancers other than breast and ovary.
Settore MED/06 - Oncologia Medica
Di Gaudio, F., Calo, V., La Paglia, L., Bruno, L., Di Piazza, F., Margarese, N., et al. (2012). What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary?. CURRENT WOMEN'S HEALTH REVIEWS, 8, 65-71 [http://dx.doi.org/10.2174/157340412799079327].
File in questo prodotto:
File Dimensione Formato  
What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary.pdf

Solo gestori archvio

Descrizione: Main article
Dimensione 227.43 kB
Formato Adobe PDF
227.43 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/77918
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact